Effects of Levofloxacin on Blood Lymphocyte Apoptosis in Patients with Pulmonary Tuberculosis: an In Vitro Study


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The effects of a fluroquinolone levofloxacin on apoptosis of peripheral blood lymphocytes from patients with infiltrative pulmonary tuberculosis were studied in vitro. It was found that levofloxacin stimulated apoptotic cell death in tuberculosis. Addition of levofloxacin to cell suspension from patients with drug-susceptible form of tuberculosis led to an increase in the number of CD95+ and AnnV+ lymphocytes. In patients with drug-resistant form of tuberculosis, only the number of apoptotic lymphocytes, but not the count of CD95+ cells increased under these conditions.

About the authors

V. A. Serebryakova

Siberian State Medical University, Ministry of Health of the Russian Federation

Author for correspondence.
Email: serebryakova-val@mail.ru
Russian Federation, Tomsk

O. I. Urazova

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: serebryakova-val@mail.ru
Russian Federation, Tomsk

V. V. Novitsky

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: serebryakova-val@mail.ru
Russian Federation, Tomsk

A. I. Vengerovskii

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: serebryakova-val@mail.ru
Russian Federation, Tomsk

T. E. Kononova

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: serebryakova-val@mail.ru
Russian Federation, Tomsk

O. A. Vasil’eva

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: serebryakova-val@mail.ru
Russian Federation, Tomsk

A. E. Beresneva

Siberian State Medical University, Ministry of Health of the Russian Federation

Email: serebryakova-val@mail.ru
Russian Federation, Tomsk


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies